32 results
8-K/A
EX-99.1
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
a pandemic. As of the date of the consolidated financial statements were issued, Elicio’s operations have not been significantly impacted by the COVID-19 … , the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act, among other
8-K/A
EX-99.2
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
disease 2019 (COVID-19) outbreak a pandemic. As of the date of the consolidated financial statements were issued, Elicio’s operations have not been
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
be affected by the ongoing COVID-19 pandemic, natural disasters, such as floods or fires, or such facilities could face manufacturing issues … ” include “qualified pandemic or epidemic products”, such as those for COVID-19. For these immunities to apply, the Secretary of the U.S. Department of Health
8-K
EX-99.5
13qwj
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
9uzb2ood28waam6
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
EX-10.34
2yk67b 1wagujre8a
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
6kdnqfvu5fxbene mv
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
424B5
683srh2x9gmnyf t4dof
24 May 22
Prospectus supplement for primary offering
4:02pm
424B3
xjaa8n2 bn
24 May 22
Prospectus supplement
4:01pm
S-3
oymzeb0y
16 May 22
Shelf registration
5:23pm
DEF 14A
a4cx64xhq hdq
27 Apr 22
Definitive proxy
4:04pm